Articles by Janet Lambert

1. Why We Need A New Model To Appropriately Value The Promise Of Regenerative Medicines & Advanced Therapies 7/27/2020

   With durable or curative therapies near at hand for a range of severe diseases and disorders, it has become clear that payors need a different model for assessing the value of these innovative treatments.

2. Creating A Roadmap For The Development And Manufacture Of Gene Therapies 5/4/2020

   The cell and gene therapy sector is in need of a similar revolution, but instead of a “standard gauge,” there is a need for clear, evidence-based industry standards and best practices for manufacturing these innovative technologies.